Table 1 Comparison of SLE patients to healthy controls

LV EF (%)

64.1±9.4

68.4±5.4

p<0.05

LV EDV (ml)

152.7±31.0

129.1±30.9

p<0.01

LV ESV (ml)

56.3±24.3

41.7±16.0

p<0.01

LV SV (ml)

96.5±19.5

87.3±16.8

p=n.s.

LV Cardiac output (l/min)

7.0±1.9

6.1±1.2

p<0.05

MAPSE (mm)

12.9±2.7

14.6±4.1

p=n.s.

LV EDV/BSA (ml/m²)

85.7±17.5

73.6±14.2

p<0.01

LV ESV/BSA (ml/m²)

31.8±15.2

23.8±8.3

p<0.05

LV SV/BSA (ml/m²)

53.9±9.6

49.8±7.0

p=n.s.

RV EF (%)

52.9±9.0

60.2±7.4

p<0.01

RV EDV (ml)

178.0±29.5

127.1±34.6

p<0.0001

RV ESV (ml)

83.8±20.6

50.8±17.3

p<0.0001

RV SV (ml)

94.2±24.0

76.3±21.2

p<0.01

RV Cardiac output (l/min)

6.8±2.1

5.3±1.6

p<0.01

TAPSE (mm)

23.3±6.0

20.1±4.7

p<0.05

RV EDV/BSA (ml/m²)

52.5±11.5

43.5±10.9

p<0.01

RV ESV/BSA (ml/m²)

47.2±12.7

28.9±8.8

p<0.0001

RV SV/BSA (ml/m²)

52.5±11.5

43.5±10.9

p<0.001

Wall mass (g)

73.1±19.2

63.3±20.9

p=n.s.

Wall mass/BSA (g/m²)

40.7±9.0

35.9±9.5

p=n.s.